Asia · Markets & Finance · Mint

Sun Pharma to consider ₹15,000 crore NCD issue; board meeting on 12 October

Published by Mint · India

Sun Pharmaceutical Industries will hold a Board meeting on October 12, 2026, to approve the issuance of non-convertible debentures worth up to ₹15,000 crore to fund a bridge loan…

Read the full article on Mint Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.livemint.com)

Also worth reading

Business Standard

Sebi brings risk-o-meter for debt securities; eases norms for debt-raising

The Economic Times

Lightning hits IndiGo flight; all 110 onboard safe

The Straits Times Business

SingPost trials digital stamps to make mailing letters ‘as seamless as sending a message’

SCMP Business

Hong Kong tech index to harness fast-growth companies in bid for better performance

Moneycontrol

Varun Dhawan becomes investor in Shark Tank India brand Better Nutrition after buying a farm, says ‘This is quite personal for me’

The Edge Singapore